Back to VRTX
PRINCIPAL FINANCIAL GROUP INC → VRTX
PRINCIPAL FINANCIAL GROUP INC VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
14
Latest value
$230.2M
Q3 2026
Peak value
$230.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $124K |
| Q3 2025 | $22M |
| Q3 2025 | $156.2M |
| Q3 2025 | $3M |
| Q4 2025 | $26.6M |
| Q4 2025 | $83K |
| Q4 2025 | $185.8M |
| Q4 2025 | $2.4M |
| Q1 2026 | $5.1M |
| Q1 2026 | $185.4M |
| Q2 2026 | $191.4M |
| Q2 2026 | $2.1M |
| Q3 2026 | $1.7M |
| Q3 2026 | $230.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $230.2M | 440.3K | — | — |
| Q3 2026 | $1.7M | 3.2K | — | — |
| Q2 2026 | $2.1M | 4.2K | — | — |
| Q2 2026 | $191.4M | 385.3K | — | — |
| Q1 2026 | $185.4M | 415.2K | — | — |
| Q1 2026 | $5.1M | 11.3K | — | — |
| Q4 2025 | $2.4M | 5.3K | — | — |
| Q4 2025 | $185.8M | 409.8K | — | — |
| Q4 2025 | $83K | 4.1K | — | — |
| Q4 2025 | $26.6M | 1.33M | — | — |
| Q3 2025 | $3M | 7.6K | — | — |
| Q3 2025 | $156.2M | 398.9K | — | — |
| Q3 2025 | $22M | 887.9K | — | — |
| Q3 2025 | $124K | 5.0K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B